Compare Stocks → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:ACAINASDAQ:APOPOTCMKTS:ECIAOTCMKTS:NEMD Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACAISafeplus International$0.00$0.00$0.00▼$0.20$3KN/AN/AN/AAPOPCellect Biotechnology$13.17+0.4%$11.51$6.64▼$35.52$12.87M1.87479,845 shs17,400 shsECIAEncision$0.44$0.54$0.25▼$0.75$5.22M0.37591 shsN/ANEMDiNeedMD$0.00$0.00$0.00▼$0.00$10K-0.58N/AN/A7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACAISafeplus International0.00%0.00%0.00%0.00%-99.34%APOPCellect Biotechnology0.00%0.00%0.00%0.00%0.00%ECIAEncision0.00%-37.14%-12.00%-4.35%+12.82%NEMDiNeedMD0.00%0.00%0.00%0.00%0.00%The #1 Crypto for 2024 (Ad)5 Tiny Cryptos That Could Soar During 2024 Crypto Bull Run One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.Get His #1 Coin For 2024 FREE By Clicking HereMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACAISafeplus InternationalN/AN/AN/AN/AN/AN/AN/AN/AAPOPCellect BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/ANEMDiNeedMDN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACAISafeplus InternationalN/AN/AN/AN/AAPOPCellect BiotechnologyN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/ANEMDiNeedMDN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACAISafeplus InternationalN/AN/AN/AN/AN/AN/AAPOPCellect BiotechnologyN/AN/AN/AN/A$4.77 per shareN/AECIAEncision$7.35M0.71N/AN/A$0.21 per share2.10NEMDiNeedMDN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACAISafeplus InternationalN/AN/A0.00∞N/AN/AN/AN/AN/AAPOPCellect Biotechnology-$5.62MN/A0.00∞N/AN/AN/AN/AN/AECIAEncision-$320K-$0.04N/A∞N/A-6.51%-18.97%-10.50%6/20/2024 (Estimated)NEMDiNeedMDN/AN/A0.00∞N/AN/AN/AN/AN/ALatest ECIA, APOP, ACAI, and NEMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/14/2024Q3 2024ECIAEncisionN/A-$0.02-$0.02-$0.02N/A$1.58 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACAISafeplus InternationalN/AN/AN/AN/AN/AAPOPCellect BiotechnologyN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/ANEMDiNeedMDN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACAISafeplus InternationalN/AN/AN/AAPOPCellect BiotechnologyN/A3.013.01ECIAEncision0.112.551.08NEMDiNeedMDN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipACAISafeplus InternationalN/AAPOPCellect Biotechnology4.84%ECIAEncision8.20%NEMDiNeedMDN/AInsider OwnershipCompanyInsider OwnershipACAISafeplus International4.02%APOPCellect BiotechnologyN/AECIAEncision40.87%NEMDiNeedMDN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableACAISafeplus International225.38 million24.36 millionNot OptionableAPOPCellect Biotechnology2,020977,000N/ANot OptionableECIAEncision3111.86 million7.02 millionNot OptionableNEMDiNeedMD348.01 millionN/ANot OptionableECIA, APOP, ACAI, and NEMD HeadlinesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeTop HeadlinesAkebia Therapeutics Surges on FDA Approval for Anemia TreatmentApril 3, 2024 9:10 AMView Akebia Therapeutics Surges on FDA Approval for Anemia TreatmentHow and When to Roll Your Options Positions? March 27, 2024 9:32 AMView How and When to Roll Your Options Positions? DexCom Stock Gains from GLP-1 Diabetic UsersApril 2, 2024 7:16 AMView DexCom Stock Gains from GLP-1 Diabetic UsersSilicon Motion Proves That AI in Motion Stays in MotionApril 16, 2024 11:42 AMView Silicon Motion Proves That AI in Motion Stays in MotionPriceSmart Could Be the Smartest Buy of the YearApril 11, 2024 7:35 AMView PriceSmart Could Be the Smartest Buy of the YearAll Headlines Company DescriptionsSafeplus InternationalOTCMKTS:ACAISafeplus International Holdings Limited develops and markets various technologies for the medical device industries. It is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020. Safeplus International Holdings Limited was founded in 1963 and is based in Pittsford, New York.Cellect BiotechnologyNASDAQ:APOPCellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.EncisionOTCMKTS:ECIAEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.iNeedMDOTCMKTS:NEMDiNeedMD Holdings, Inc. is a medical device company, which engages in the development and provision of disposable devices used in the diagnosis, prevention, and monitoring of cardiovascular diseases. It offers EKG Glove, a medical device that used in diagnostic electrocardiograms. The company was founded by Govindan Gopinathan on February 1, 2012 and is headquartered in New York, NY. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.